The global market for Oral Antidiabetic (OAD) Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Diabetic is the condition where the sugar (glucose) level is high in the blood or the production of the insulin is inadequate. Diabetes main type the very first one is Type 1 and the second is Type 2, both the diabetic are most commonly find in the current scenario, apart from this many other diabetics case are also been listed as gestational diabetes and others. Various treatment method are present in the market injection, oral and others. The mostly used method of treatment or managing the diabetes is the oral.

North America has the 44.3 million population with diabetes in 2015 according to the IDF, same as Europe have 59.8 million in 2015 according to IDF and Asia Pacific has 60% diabetic population as compared with world according to Asian Diabetes Prevention Initiative.

This report aims to provide a comprehensive presentation of the global market for Oral Antidiabetic (OAD) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Antidiabetic (OAD) Treatment.

The Oral Antidiabetic (OAD) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Antidiabetic (OAD) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Antidiabetic (OAD) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oral Antidiabetic (OAD) Treatment Market Report

Report Metric	Details
Report Name	Oral Antidiabetic (OAD) Treatment Market
Segment by Type	Sulphonylureas Biguanides Intestinal α-Glucosidase Inhibitors Others
Segment by Application	Hospital Clinics Diabetics Treatment Centres Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Eli Lilly, Merck, Sanofi, AstraZeneca, Glenmark, Novartis, Boehringer Ingelheim, Novo Nordisk, Mannkind
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Antidiabetic (OAD) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oral Antidiabetic (OAD) Treatment Market report?

Ans: The main players in the Oral Antidiabetic (OAD) Treatment Market are Pfizer, Eli Lilly, Merck, Sanofi, AstraZeneca, Glenmark, Novartis, Boehringer Ingelheim, Novo Nordisk, Mannkind

What are the Application segmentation covered in the Oral Antidiabetic (OAD) Treatment Market report?

Ans: The Applications covered in the Oral Antidiabetic (OAD) Treatment Market report are Hospital, Clinics, Diabetics Treatment Centres, Others

What are the Type segmentation covered in the Oral Antidiabetic (OAD) Treatment Market report?

Ans: The Types covered in the Oral Antidiabetic (OAD) Treatment Market report are Sulphonylureas, Biguanides, Intestinal α-Glucosidase Inhibitors, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Sulphonylureas

1.2.3 Biguanides

1.2.4 Intestinal α-Glucosidase Inhibitors

1.2.5 Others

1.3 Market by Application

1.3.1 Global Oral Antidiabetic (OAD) Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Diabetics Treatment Centres

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oral Antidiabetic (OAD) Treatment Market Perspective (2020-2031)

2.2 Global Oral Antidiabetic (OAD) Treatment Growth Trends by Region

2.2.1 Global Oral Antidiabetic (OAD) Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oral Antidiabetic (OAD) Treatment Historic Market Size by Region (2020-2025)

2.2.3 Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Region (2026-2031)

2.3 Oral Antidiabetic (OAD) Treatment Market Dynamics

2.3.1 Oral Antidiabetic (OAD) Treatment Industry Trends

2.3.2 Oral Antidiabetic (OAD) Treatment Market Drivers

2.3.3 Oral Antidiabetic (OAD) Treatment Market Challenges

2.3.4 Oral Antidiabetic (OAD) Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oral Antidiabetic (OAD) Treatment Players by Revenue

3.1.1 Global Top Oral Antidiabetic (OAD) Treatment Players by Revenue (2020-2025)

3.1.2 Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Oral Antidiabetic (OAD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oral Antidiabetic (OAD) Treatment Revenue

3.4 Global Oral Antidiabetic (OAD) Treatment Market Concentration Ratio

3.4.1 Global Oral Antidiabetic (OAD) Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oral Antidiabetic (OAD) Treatment Revenue in 2024

3.5 Global Key Players of Oral Antidiabetic (OAD) Treatment Head office and Area Served

3.6 Global Key Players of Oral Antidiabetic (OAD) Treatment, Product and Application

3.7 Global Key Players of Oral Antidiabetic (OAD) Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Antidiabetic (OAD) Treatment Breakdown Data by Type

4.1 Global Oral Antidiabetic (OAD) Treatment Historic Market Size by Type (2020-2025)

4.2 Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Type (2026-2031)

5 Oral Antidiabetic (OAD) Treatment Breakdown Data by Application

5.1 Global Oral Antidiabetic (OAD) Treatment Historic Market Size by Application (2020-2025)

5.2 Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oral Antidiabetic (OAD) Treatment Market Size (2020-2031)

6.2 North America Oral Antidiabetic (OAD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2020-2025)

6.4 North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oral Antidiabetic (OAD) Treatment Market Size (2020-2031)

7.2 Europe Oral Antidiabetic (OAD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2020-2025)

7.4 Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size (2020-2031)

8.2 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oral Antidiabetic (OAD) Treatment Market Size (2020-2031)

9.2 Latin America Oral Antidiabetic (OAD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country (2020-2025)

9.4 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size (2020-2031)

10.2 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Oral Antidiabetic (OAD) Treatment Introduction

11.1.4 Pfizer Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Eli Lilly

11.2.1 Eli Lilly Company Details

11.2.2 Eli Lilly Business Overview

11.2.3 Eli Lilly Oral Antidiabetic (OAD) Treatment Introduction

11.2.4 Eli Lilly Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

11.2.5 Eli Lilly Recent Development

11.3 Merck

11.3.1 Merck Company Details

11.3.2 Merck Business Overview

11.3.3 Merck Oral Antidiabetic (OAD) Treatment Introduction

11.3.4 Merck Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

11.3.5 Merck Recent Development

11.4 Sanofi

11.4.1 Sanofi Company Details

11.4.2 Sanofi Business Overview

11.4.3 Sanofi Oral Antidiabetic (OAD) Treatment Introduction

11.4.4 Sanofi Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

11.4.5 Sanofi Recent Development

11.5 AstraZeneca

11.5.1 AstraZeneca Company Details

11.5.2 AstraZeneca Business Overview

11.5.3 AstraZeneca Oral Antidiabetic (OAD) Treatment Introduction

11.5.4 AstraZeneca Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

11.5.5 AstraZeneca Recent Development

11.6 Glenmark

11.6.1 Glenmark Company Details

11.6.2 Glenmark Business Overview

11.6.3 Glenmark Oral Antidiabetic (OAD) Treatment Introduction

11.6.4 Glenmark Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

11.6.5 Glenmark Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Oral Antidiabetic (OAD) Treatment Introduction

11.7.4 Novartis Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

11.7.5 Novartis Recent Development

11.8 Boehringer Ingelheim

11.8.1 Boehringer Ingelheim Company Details

11.8.2 Boehringer Ingelheim Business Overview

11.8.3 Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Introduction

11.8.4 Boehringer Ingelheim Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

11.8.5 Boehringer Ingelheim Recent Development

11.9 Novo Nordisk

11.9.1 Novo Nordisk Company Details

11.9.2 Novo Nordisk Business Overview

11.9.3 Novo Nordisk Oral Antidiabetic (OAD) Treatment Introduction

11.9.4 Novo Nordisk Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

11.9.5 Novo Nordisk Recent Development

11.10 Mannkind

11.10.1 Mannkind Company Details

11.10.2 Mannkind Business Overview

11.10.3 Mannkind Oral Antidiabetic (OAD) Treatment Introduction

11.10.4 Mannkind Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

11.10.5 Mannkind Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Sulphonylureas

Table 3. Key Players of Biguanides

Table 4. Key Players of Intestinal α-Glucosidase Inhibitors

Table 5. Key Players of Others

Table 6. Global Oral Antidiabetic (OAD) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Oral Antidiabetic (OAD) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Oral Antidiabetic (OAD) Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Oral Antidiabetic (OAD) Treatment Market Share by Region (2020-2025)

Table 10. Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Oral Antidiabetic (OAD) Treatment Market Share by Region (2026-2031)

Table 12. Oral Antidiabetic (OAD) Treatment Market Trends

Table 13. Oral Antidiabetic (OAD) Treatment Market Drivers

Table 14. Oral Antidiabetic (OAD) Treatment Market Challenges

Table 15. Oral Antidiabetic (OAD) Treatment Market Restraints

Table 16. Global Oral Antidiabetic (OAD) Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Oral Antidiabetic (OAD) Treatment Market Share by Players (2020-2025)

Table 18. Global Top Oral Antidiabetic (OAD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic (OAD) Treatment as of 2024)

Table 19. Ranking of Global Top Oral Antidiabetic (OAD) Treatment Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Oral Antidiabetic (OAD) Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Oral Antidiabetic (OAD) Treatment, Headquarters and Area Served

Table 22. Global Key Players of Oral Antidiabetic (OAD) Treatment, Product and Application

Table 23. Global Key Players of Oral Antidiabetic (OAD) Treatment, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Oral Antidiabetic (OAD) Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Type (2020-2025)

Table 27. Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Type (2026-2031)

Table 29. Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Application (2020-2025)

Table 31. Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Application (2026-2031)

Table 33. North America Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 48. Pfizer Company Details

Table 49. Pfizer Business Overview

Table 50. Pfizer Oral Antidiabetic (OAD) Treatment Product

Table 51. Pfizer Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025) & (US$ Million)

Table 52. Pfizer Recent Development

Table 53. Eli Lilly Company Details

Table 54. Eli Lilly Business Overview

Table 55. Eli Lilly Oral Antidiabetic (OAD) Treatment Product

Table 56. Eli Lilly Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025) & (US$ Million)

Table 57. Eli Lilly Recent Development

Table 58. Merck Company Details

Table 59. Merck Business Overview

Table 60. Merck Oral Antidiabetic (OAD) Treatment Product

Table 61. Merck Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025) & (US$ Million)

Table 62. Merck Recent Development

Table 63. Sanofi Company Details

Table 64. Sanofi Business Overview

Table 65. Sanofi Oral Antidiabetic (OAD) Treatment Product

Table 66. Sanofi Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025) & (US$ Million)

Table 67. Sanofi Recent Development

Table 68. AstraZeneca Company Details

Table 69. AstraZeneca Business Overview

Table 70. AstraZeneca Oral Antidiabetic (OAD) Treatment Product

Table 71. AstraZeneca Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025) & (US$ Million)

Table 72. AstraZeneca Recent Development

Table 73. Glenmark Company Details

Table 74. Glenmark Business Overview

Table 75. Glenmark Oral Antidiabetic (OAD) Treatment Product

Table 76. Glenmark Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025) & (US$ Million)

Table 77. Glenmark Recent Development

Table 78. Novartis Company Details

Table 79. Novartis Business Overview

Table 80. Novartis Oral Antidiabetic (OAD) Treatment Product

Table 81. Novartis Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025) & (US$ Million)

Table 82. Novartis Recent Development

Table 83. Boehringer Ingelheim Company Details

Table 84. Boehringer Ingelheim Business Overview

Table 85. Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Product

Table 86. Boehringer Ingelheim Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025) & (US$ Million)

Table 87. Boehringer Ingelheim Recent Development

Table 88. Novo Nordisk Company Details

Table 89. Novo Nordisk Business Overview

Table 90. Novo Nordisk Oral Antidiabetic (OAD) Treatment Product

Table 91. Novo Nordisk Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025) & (US$ Million)

Table 92. Novo Nordisk Recent Development

Table 93. Mannkind Company Details

Table 94. Mannkind Business Overview

Table 95. Mannkind Oral Antidiabetic (OAD) Treatment Product

Table 96. Mannkind Revenue in Oral Antidiabetic (OAD) Treatment Business (2020-2025) & (US$ Million)

Table 97. Mannkind Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Oral Antidiabetic (OAD) Treatment Picture

Figure 2. Global Oral Antidiabetic (OAD) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oral Antidiabetic (OAD) Treatment Market Share by Type: 2024 VS 2031

Figure 4. Sulphonylureas Features

Figure 5. Biguanides Features

Figure 6. Intestinal α-Glucosidase Inhibitors Features

Figure 7. Others Features

Figure 8. Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Oral Antidiabetic (OAD) Treatment Market Share by Application: 2024 VS 2031

Figure 10. Hospital Case Studies

Figure 11. Clinics Case Studies

Figure 12. Diabetics Treatment Centres Case Studies

Figure 13. Others Case Studies

Figure 14. Oral Antidiabetic (OAD) Treatment Report Years Considered

Figure 15. Global Oral Antidiabetic (OAD) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Oral Antidiabetic (OAD) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Oral Antidiabetic (OAD) Treatment Market Share by Region: 2024 VS 2031

Figure 18. Global Oral Antidiabetic (OAD) Treatment Market Share by Players in 2024

Figure 19. Global Top Oral Antidiabetic (OAD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic (OAD) Treatment as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Oral Antidiabetic (OAD) Treatment Revenue in 2024

Figure 21. North America Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Oral Antidiabetic (OAD) Treatment Market Share by Country (2020-2031)

Figure 23. United States Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Oral Antidiabetic (OAD) Treatment Market Share by Country (2020-2031)

Figure 27. Germany Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Share by Region (2020-2031)

Figure 35. China Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Oral Antidiabetic (OAD) Treatment Market Share by Country (2020-2031)

Figure 43. Mexico Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Share by Country (2020-2031)

Figure 47. Turkey Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Oral Antidiabetic (OAD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Pfizer Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

Figure 51. Eli Lilly Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

Figure 52. Merck Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

Figure 53. Sanofi Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

Figure 54. AstraZeneca Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

Figure 55. Glenmark Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

Figure 56. Novartis Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

Figure 57. Boehringer Ingelheim Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

Figure 58. Novo Nordisk Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

Figure 59. Mannkind Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Oral Antidiabetic Drugs Market Insights Forecast to 2030

Oral Anti diabetes Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Antidiabetic Agents Market Insights Forecast to 2030

Global Type 2 Diabetes Medicines Market Research Report 2024

Global Diabetes Drugs Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Diabetes Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti diabetic Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diabetes Mellitus Treatment Market Insights Forecast to 2030

Diabetes Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Injectable Drugs For Type 2 Diabete Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diabetes Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Medicines for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Insulin Market Research Report 2025

Injectable Drugs For Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Type 1 Diabetes Treatment Market Insights Forecast to 2030

Global Diabetes Associated Ophthalmic Treatment Market Research Report 2025

Global Type 2 Diabetes Mellitus Treatment Market Research Report 2024

Oral Hypoglycemic Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hypoglycemic Drugs Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions